Carmichael Hill & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $1.34M | Buy |
6,760
+71
| +1% | +$14K | 0.47% | 48 |
|
2024
Q2 | $1.15M | Buy |
6,689
+13
| +0.2% | +$2.23K | 0.45% | 50 |
|
2024
Q1 | $1.22M | Buy |
6,676
+12
| +0.2% | +$2.19K | 0.48% | 50 |
|
2023
Q4 | $1.03M | Buy |
6,664
+14
| +0.2% | +$2.17K | 0.43% | 54 |
|
2023
Q3 | $991K | Buy |
6,650
+13
| +0.2% | +$1.94K | 0.46% | 52 |
|
2023
Q2 | $894K | Buy |
6,637
+1,213
| +22% | +$163K | 0.4% | 56 |
|
2023
Q1 | $864K | Buy |
5,424
+134
| +3% | +$21.4K | 0.42% | 54 |
|
2022
Q4 | $855K | Sell |
5,290
-3
| -0.1% | -$485 | 0.44% | 50 |
|
2022
Q3 | $710K | Buy |
5,293
+11
| +0.2% | +$1.48K | 0.38% | 58 |
|
2022
Q2 | $809K | Sell |
5,282
-991
| -16% | -$152K | 0.42% | 52 |
|
2022
Q1 | $1.02M | Buy |
6,273
+1,094
| +21% | +$177K | 0.47% | 44 |
|
2021
Q4 | $701K | Buy |
5,179
+36
| +0.7% | +$4.87K | 0.31% | 61 |
|
2021
Q3 | $555K | Buy |
5,143
+12
| +0.2% | +$1.3K | 0.28% | 70 |
|
2021
Q2 | $578K | Buy |
5,131
+21
| +0.4% | +$2.37K | 0.29% | 67 |
|
2021
Q1 | $553K | Buy |
5,110
+34
| +0.7% | +$3.68K | 0.3% | 67 |
|
2020
Q4 | $544K | Buy |
5,076
+694
| +16% | +$74.4K | 0.32% | 63 |
|
2020
Q3 | $384K | Buy |
4,382
+267
| +6% | +$23.4K | 0.26% | 77 |
|
2020
Q2 | $404K | Buy |
4,115
+580
| +16% | +$56.9K | 0.3% | 69 |
|
2020
Q1 | $269K | Buy |
3,535
+126
| +4% | +$9.59K | 0.24% | 83 |
|
2019
Q4 | $302K | Sell |
3,409
-73
| -2% | -$6.47K | 0.21% | 88 |
|
2019
Q3 | $264K | Sell |
3,482
-319
| -8% | -$24.2K | 0.26% | 88 |
|
2019
Q2 | $276K | Sell |
3,801
-62
| -2% | -$4.5K | 0.27% | 90 |
|
2019
Q1 | $311K | Sell |
3,863
-97
| -2% | -$7.81K | 0.32% | 81 |
|
2018
Q4 | $365K | Sell |
3,960
-113
| -3% | -$10.4K | 0.42% | 69 |
|
2018
Q3 | $385K | Buy |
4,073
+2
| +0% | +$189 | 0.37% | 73 |
|
2018
Q2 | $377K | Buy |
4,071
+2
| +0% | +$185 | 0.41% | 69 |
|
2018
Q1 | $385K | Buy |
4,069
+2
| +0% | +$189 | 0.42% | 69 |
|
2017
Q4 | $393K | Buy |
+4,067
| New | +$393K | 0.43% | 71 |
|